These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4906983)

  • 1. [Chemical structure and blood glucose lowering effect].
    Bänder A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():429-40. PubMed ID: 4906983
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mode of action of blood glucose lowering biguanides: clinical aspects].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():678-84. PubMed ID: 4906985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
    Pfeiffer EF
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():477-502. PubMed ID: 4906024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypoglycemic sulfonamides].
    Loubatières AL
    Actual Pharmacol (Paris); 1968; 21():173-90. PubMed ID: 4888764
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the beta-cytotropic effect of glymidine sodium (glycodiazine), glucagon, and isopropylnoradrenaline in rats].
    Losert W; Loge O; Jahn P
    Arzneimittelforschung; 1973 Sep; 23(9):1251-60. PubMed ID: 4149442
    [No Abstract]   [Full Text] [Related]  

  • 6. [The discovery of hypoglycemic sulfonamides and particularly of their action mechanism].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():20-56. PubMed ID: 4906982
    [No Abstract]   [Full Text] [Related]  

  • 7. [The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].
    Mariani MM
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():256-70. PubMed ID: 5371307
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current views on the mode of action of blood glucose lowering biguanides].
    Segre G
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():627-35. PubMed ID: 4984396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin liberation from the pancreas by sulfonylurea].
    Pfaff W; Schöne HH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study of oral treatment in diabetes].
    Romani JD
    Sem Hop; 1969 May; 45(25):1768-76. PubMed ID: 4308469
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current views on the mode of action of hypoglycemic sulfonamides].
    Creutzfeldt W
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():201-15. PubMed ID: 4906019
    [No Abstract]   [Full Text] [Related]  

  • 13. [Derivatives of sulfamoyl-aryloxyalkyl carboxylic acids with hypoglycemic action].
    Braha S; Oniscu C; Simionovici M
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):316-20. PubMed ID: 4089334
    [No Abstract]   [Full Text] [Related]  

  • 14. A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
    Sugawara K; Honda K; Reien Y; Yokoi N; Seki C; Takahashi H; Minami K; Mori I; Matsumoto A; Nakaya H; Seino S
    PLoS One; 2016; 11(10):e0164785. PubMed ID: 27764176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acylaminoalkylbenzolsulfonylsemicarbazides as blood sugar decreasing substances].
    Aumüller W; Fauland E; Hagedorn A; Heerdt R; Hübner M; Muth K; Weber H; Weyer R; Bänder A; Pfaff W; Schmidt FH; Stork H
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1350-4. PubMed ID: 5394453
    [No Abstract]   [Full Text] [Related]  

  • 16. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral antidiabetics. Dose, plasma concentration and effect].
    Ariëns EJ
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():143-76. PubMed ID: 4392071
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of ouabain on insulin secretion in the dog.
    Triner L; Papayoanou J; Killian P; Vulliemoz Y; Castany R; Nahas GG
    Circ Res; 1969 Aug; 25(2):119-29. PubMed ID: 5806158
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mode of action of blood glucose lowering sulfonamides. Other extrapancreatic effects].
    Madsen J
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():415-28. PubMed ID: 4906023
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of glycodiazin and glybenclamide upon insulin secretion in vitro.
    Malaisse W; Malaisse-Lagae F
    Eur J Pharmacol; 1970 Jan; 9(1):93-8. PubMed ID: 5434298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.